INS and metabolic syndrome: Adiponectin (ADP) is one of the key adipokines with various beneficial effects related to obesity and metabolic syndromes, including improving glucose and lipid metabolism, enhancing insulin sensitivity, reducing oxidative stress and inflammation, promoting ceramides degradation, and stimulating adipose tissue vascularity [41].